<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29267610</article-id><article-id pub-id-type="pmc">5731314</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0116</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Validation of Four Prediction Scores for Cardiac Surgery-Associated
Acute Kidney Injury in Chinese Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Wuhua</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jiarui</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Bo</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chunsheng</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Teng</surname><given-names>Jie</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Xiaoqiang</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="c1"/></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Nephrology of Zhongshan Hospital of Fudan University
Shanghai Medical College, Shanghai, China.</aff><aff id="aff2">
<label>2</label> Shanghai Kidney and Dialysis Institute of Fudan University Shanghai
Medical College, Shanghai, China.</aff><aff id="aff3">
<label>3</label> Department of Cardiovascular Surgery of Zhongshan Hospital of Fudan
University Shanghai Medical College, Shanghai, China.</aff><aff id="aff4">
<label>4</label> Shanghai Kidney and Blood Purification Laboratory of Zhongshan
Hospital of Fudan University Shanghai Medical College, Shanghai, China.</aff><author-notes><corresp id="c1">Correspondence Address: Xiaoqiang Ding, Department of Nephrology,
Zhongshan Hospital, Fudan University Shanghai Medical College, 180 Fenglin Road,
Xuhui District, Shanghai 200032, PR China. E-mail:
<email>ding.xiaoqiang@zs-hospital.sh.cn</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2017</year></pub-date><volume>32</volume><issue>6</issue><fpage>481</fpage><lpage>486</lpage><history><date date-type="received"><day>27</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To assess the clinical value of four models for the prediction of cardiac
surgery-associated acute kidney injury (CSA-AKI) and severe AKI which renal
replacement therapy was needed (RRT-AKI) in Chinese patients.</p></sec><sec><title>Methods</title><p>1587 patients who underwent cardiac surgery in the department of cardiac
surgery in the Zhongshan Hospital, Fudan University, between January 2013
and December 2013 were enrolled in this research. Evaluating the predicting
value for cardiac surgery-associated AKI (AKICS score) and RRT-AKI
(Cleveland score, SRI and Mehta score) by Hosmer-Lemeshow goodness-of-fit
test for the calibration and area under receiver operating characteristic
curve (AUROC) for the discrimination.</p></sec><sec><title>Results</title><p>Based on 2012 KDIGO (Kidney Disease: Improving Global Outcomes) AKI
definition, the incidence of AKI and RRT-AKI was 37.4% (594/1587) and 1.1%
(18/1587), respectively. The mortality of AKI and RRT-AKI was 6.1% (36/594)
and 66.7% (12/18), respectively, while the total mortality was 2.8%
(44/1587). The discrimination (AUROC=0.610) for the prediction of CSA-AKI of
AKICS was low, while the calibration (x<sup>2</sup>=7.55,
<italic>P</italic>=0.109) was fair. For the prediction of RRT-AKI, the
discrimination of Cleveland score (AUROC=0.684), Mehta score (AUROC=0.708)
and SRI (AUROC=0.622) were not good; while the calibration of them were fair
(Cleveland score x<sup>2</sup>=1.918, <italic>P</italic>=0.166; Mehta score
x<sup>2</sup>=9.209, <italic>P</italic>=0.238; SRI x<sup>2</sup>=2.976,
<italic>P</italic>=0.271).</p></sec><sec><title>Conclusion</title><p>In our single-center study, based upon valve surgery dominant and less
diabetes mellitus patients, according to KDIGO AKI definition, the
predictive value of the four models, combining discrimination and
calibration, for respective primary event, were not convincible.</p></sec></abstract><kwd-group><kwd>Acute Kidney Injury</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Risk Assessment</kwd><kwd>Renal Replacement Therapy</kwd><kwd>Validation Studies</kwd></kwd-group><funding-group><award-group><funding-source>Shanghai science and technology committee</funding-source><award-id>14DZ2260200</award-id></award-group><funding-statement>Clinical key specialist construction project and Shanghai science
and technology committee scientific research projects
14DZ2260200.</funding-statement></funding-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AKI</td><td align="left" rowspan="1" colspan="1">= Acute kidney injury</td></tr><tr><td align="left" rowspan="1" colspan="1">AUROC</td><td align="left" rowspan="1" colspan="1">= Area under receiver operating characteristics curve</td></tr><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">= Coronary artery bypass grafting</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">CSA-AKI</td><td align="left" rowspan="1" colspan="1">= Cardiac surgery-associated acute kidney injury</td></tr><tr><td align="left" rowspan="1" colspan="1">KDIGO</td><td align="left" rowspan="1" colspan="1">= Kidney Disease: Improving Global Outcomes</td></tr><tr><td align="left" rowspan="1" colspan="1">RRT-AKI</td><td align="left" rowspan="1" colspan="1">= Renal replacement therapy-acute kidney injury</td></tr><tr><td align="left" rowspan="1" colspan="1">SCr</td><td align="left" rowspan="1" colspan="1">= Serum creatinine</td></tr><tr><td align="left" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">= Standard deviation</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>With the technique of cardiac surgery booming in the big developing countries like
China, Brazil and India, more and more complex procedures can be performed.
Meanwhile, the following complications of surgery may emerge as well, which will be
a huge burden of national health cost<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Acute kidney injury (AKI) is one of these common complications
after cardiac surgery with reported incidences over 30% while mortality increased
fourfold and even slight renal function changes were reported to influence short-
and long-term survival rates after cardiac surgery<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Since
early identifying the patients who are at high risk of developing into cardiac
surgery associated acute kidney injury (CSA-AKI) may improve prognosis, in the last
two decades various predictive models have been developed to forecast CSA-AKI or
renal replacement therapy (RRT)-AKI required after cardiac surgery. Among them,
adequate predictive value has been validated in the Caucasians cohorts<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup> in four risk scores<sup>[<xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r9" ref-type="bibr">9</xref>]</sup>. However, with the
new 2012 Kidney Disease: Improving Global Outcomes (KDIGO) AKI definition being
popularized<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, the
predictive value for predicting CSA-AKI, RRT-AKI become doubtful due to the updated
definition, with which some "subclinical AKI" can be defined.</p><p>The aim of this study is to validate the predictive value of four predictive scores
for their respective outcome in Chinese patients, in which cohort valve surgeries
are dominant, and less diabetes<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Patients</title><p>In our retrospective study, we included patients at department of cardiac surgery
between January 2013 and December 2013, and extracted data from a computerized
cardiac surgical database. Patients (aged &#x0003e; 18 years) who underwent cardiac
surgical procedures [coronary artery bypass grafting (CABG) alone, mitral or
aortic valve surgery alone, or combination of CABG and aortic or mitral valve
surgery] with cardiopulmonary bypass (CPB) were enrolled. In addition, according
to common exclusion criteria derived from these four scores, patients who were
on RRT preoperatively, those who underwent heart transplant or assist device
insertion and patients who denied access to their medical records for the
purpose of research were also excluded. In order to evaluate predictive value of
different models, the prediction scores were calculated and summed as in the
original studies<sup>[<xref rid="r6" ref-type="bibr">6</xref>-<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Patients who did not meet the original inclusion criteria for a certain model
were excluded from the analysis of that specific model. If there were more than
one cardiac surgery procedures performed during the same hospitalization, only
the data with the first surgery were considered. All the patients included were
followed until discharge or death. The study was approved by the ethical
committee of the Zhongshan Hospital and all participants provided written
informed consent before inclusion.</p></sec><sec><title>Outcomes</title><p>The four prediction scores analyzed in this study were Cleveland score, Mehta
score, SRI and AKICS score. The brief description and characteristics of the
scores were shown in <xref ref-type="table" rid="t1">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Predictors in each score.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/><col width="11%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Prediction</th><th align="center" colspan="2" rowspan="1">Cleveland Score</th><th align="center" colspan="2" rowspan="1">Mehta Score</th><th align="center" colspan="2" rowspan="1">SRI Score</th><th align="center" colspan="2" rowspan="1">AKICS Score</th></tr><tr><th colspan="2" rowspan="1">RRT-AKI</th><th colspan="2" rowspan="1">RRT-AKI</th><th colspan="2" rowspan="1">RRT-AKI</th><th colspan="2" rowspan="1">AKI</th></tr><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Definition</th><th align="center" rowspan="1" colspan="1">Score</th><th align="center" rowspan="1" colspan="1">Definition</th><th align="center" rowspan="1" colspan="1">Score</th><th align="center" rowspan="1" colspan="1">Definition</th><th align="center" rowspan="1" colspan="1">Score</th><th align="center" rowspan="1" colspan="1">Definition</th><th align="center" rowspan="1" colspan="1">Score</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Varies</td><td align="center" rowspan="1" colspan="1">Varies</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x0003e; 65</td><td align="center" rowspan="1" colspan="1">2.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Race</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Non-white</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative kidney function</td><td align="center" rowspan="1" colspan="1">SCr 1.2-2.1 mg/dL</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">SCr</td><td align="center" rowspan="1" colspan="1">Varies</td><td align="center" rowspan="1" colspan="1">GFR, 31-60 mL/min</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Preoperative SCr &#x0003e; 1.2 mg/dL</td><td align="center" rowspan="1" colspan="1">3.1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">SCr &#x0003e; 2.1 mg/dL</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">GFR &#x02264; 30 mL/min</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">CHF</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" colspan="2" rowspan="1">NYHA Class</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3 or 4</td><td align="center" rowspan="1" colspan="1">3.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Preoperative capillary glucose &#x0003e; 140
mg/dL</td><td align="center" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Recent MI (&#x0003c; 21 d)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="center" rowspan="1" colspan="1">&#x0003c; 35%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x02264; 40%</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous surgery</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative IABP</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="3" rowspan="1">Cardiogenic shock</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Timing of surgery</td><td align="center" rowspan="1" colspan="1">Emergence</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Non-selective</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x0003e; 120 min</td><td align="center" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative CVP</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x0003e; 14 cmH2O</td><td align="center" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" rowspan="1" colspan="1">LCOS</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Type of surgery</td><td align="center" rowspan="1" colspan="1">CABG only</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">CABG only</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">Other than CABG</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Combined surgery</td><td align="center" rowspan="1" colspan="1">3.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Valve only</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Aortic valve only</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">CABG + valve</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">Aortic valve + CABG</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Mitral valve only</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">Mitral valve + CABG</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Score range</td><td align="center" rowspan="1" colspan="1">0-17</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0-83</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0-8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0-20</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AKI=acute kidney injury; RRT-AKI=AKI which renal replacement therapy
is needed; CABG=coronary artery bypass grafting; CHF=congestive
heart failure; COPD=chronic obstructive pulmonary disease;
CPB=cardiopulmonary bypass; CVD=cerebral vascular disease;
CVP=central venous pressure by ICU admittance; DM=diabetes mellitus;
eGFR=estimated glomerular filtration rate, as calculated based on
the Cockcroft-Gault formulae for SRI score validation;
GFR=glomerular filtration rate; IABP=intra-aortic balloon pump;
LCOS=low cardiac output syndrome; LVEF=left ventricular ejection
fraction; MI=myocardial infarction; NYHA=New York Heart Association;
SCr=serum creatinine; SD=standard deviation</p></fn></table-wrap-foot></table-wrap><p>RRT-AKI, defined with the initiation of dialysis in the postoperative course
until the discharge, was the outcome for validation of Cleveland score, Mehta
score and SRI. The dialysis was initiated at the consulting nephrologists based
on the indication including uremia, acidosis, hyperkalemia or severe fluid
overload. CSA-AKI defined with KDIGO guideline was the outcome for validation of
AKICS score.</p><p>KDIGO AKI definition:</p><p>
<list list-type="bullet"><list-item><p>Increase in serum creatinine (SCr) by &#x02265; 0.3 mg/dL (&#x02265;
26.5 &#x000b5;mol/L) within 48 hours; or</p></list-item><list-item><p>Increase in SCr to &#x02265; 1.5 times baseline, which is known or
presumed to have occurred within the prior 7 days; or</p></list-item><list-item><p>Urine volume &#x0003c; 0.5 mL/kg/h for 6 hours.</p></list-item></list>
</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis was carried out by SPSS statistics for Windows (Version
20.0. Armonk, NY, USA, IBM Corp). Continuous variables were expressed as mean
&#x000b1; standard deviation (SD), and analyzed by unpaired t-tests, with Welch's
adjustment when necessary. Non-parametric variables were expressed as median and
25-75 percentiles and analyzed by Mann-Whitney U test.</p><p>Categorical variables were expressed as absolute (n) and relative (%) frequency,
and were analyzed by Pearson's 2-test or Fisher's exact test, whenever
appropriate. Significant level was considered with <italic>P</italic>&#x0003c;0.05.
Area under receiver operating characteristic curves (AUROC) and Hosmer-Lemeshow
goodness-of-fit test were utilized to evaluate discrimination and calibration of
every predictive risk score. Statistically, calibration refers to the agreement
between observed and predicted risk and Hosmer-Lemeshow <italic>P</italic> value
&#x0003e; 0.05 means good calibration. Discrimination refers to the capacity of
separating people with disease from people without disease and the AUROC &#x0003e;
0.80 indicates good discrimination.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 1609 patients were included in our study. After excluding cases with
preoperative RRT (n=4), left ventricular device (n=2), missing data (n=11) and
intra-operative and early-post-operative death (&#x0003c; 24h) (n=5), 1587 patients were
included to the validation (<xref ref-type="table" rid="t2">Table 2</xref>). Due to
the original exclusion criteria, the cases with emergency surgeries (n=2) were not
qualified into the validation of AKICS score.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of the patients in the validation cohort.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Preoperative</th><th align="center" rowspan="1" colspan="1">Non-AKI (N=993)</th><th align="center" rowspan="1" colspan="1">AKI (n=594)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">542 (54.6%)</td><td align="center" rowspan="1" colspan="1">434 (73.1%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, mean (SD), years</td><td align="center" rowspan="1" colspan="1">56.8 (12.3)</td><td align="center" rowspan="1" colspan="1">58.7 (11.7)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Kidney function</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Serum creatinine, mean (SD) mg/dL</td><td align="center" rowspan="1" colspan="1">0.83 (0.2)</td><td align="center" rowspan="1" colspan="1">1.04 (0.40)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;eGFR, mean (SD) mL/min/1.73 m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">109.4 (30.4)</td><td align="center" rowspan="1" colspan="1">85.9 (25.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hypertension</td><td align="center" rowspan="1" colspan="1">320 (32.2%)</td><td align="center" rowspan="1" colspan="1">204 (34.3%)</td><td align="center" rowspan="1" colspan="1">0.408</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;DM</td><td align="center" rowspan="1" colspan="1">136 (13.7%)</td><td align="center" rowspan="1" colspan="1">60 (10.1%)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;COPD</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CVD</td><td align="center" rowspan="1" colspan="1">3 (0.3%)</td><td align="center" rowspan="1" colspan="1">4 (0.7%)</td><td align="center" rowspan="1" colspan="1">0.43</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac function</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;NYHA classification &#x0003e; 2</td><td align="center" rowspan="1" colspan="1">541 (54.5%)</td><td align="center" rowspan="1" colspan="1">363 (61.1%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;LVEF &#x02264; 35%</td><td align="center" rowspan="1" colspan="1">101 (10.2%)</td><td align="center" rowspan="1" colspan="1">147 (24.4%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Previous cardiac surgery</td><td align="center" rowspan="1" colspan="1">9 (0.9%)</td><td align="center" rowspan="1" colspan="1">8 (1.3%)</td><td align="center" rowspan="1" colspan="1">0.454</td></tr><tr><td align="left" rowspan="1" colspan="1">Intraoperative</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Emergency</td><td align="center" rowspan="1" colspan="1">2 (0.2%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.531</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Valve</td><td align="center" rowspan="1" colspan="1">605 (60.9%)</td><td align="center" rowspan="1" colspan="1">428 (72.1%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CABG</td><td align="center" rowspan="1" colspan="1">342 (34.4%)</td><td align="center" rowspan="1" colspan="1">133 (22.4%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Valve + CABG</td><td align="center" rowspan="1" colspan="1">46 (4.6%)</td><td align="center" rowspan="1" colspan="1">33 (5.6%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CPB time (min)</td><td align="center" rowspan="1" colspan="1">89 (71,113)</td><td align="center" rowspan="1" colspan="1">100 (79,124)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;LCOS</td><td align="center" rowspan="1" colspan="1">3 (0.3%)</td><td align="center" rowspan="1" colspan="1">13 (2.2%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CVP, mean (SD), cmH2O</td><td align="center" rowspan="1" colspan="1">8.4 (2.7)</td><td align="center" rowspan="1" colspan="1">10.9 (2.9)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Prognosis</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;28-day mortality</td><td align="center" rowspan="1" colspan="1">8 (0.8%)</td><td align="center" rowspan="1" colspan="1">36 (6.1%)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.01</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>AKI=acute kidney injury; RRT-AKI=AKI which renal replacement therapy is
needed; CABG=coronary artery bypass grafting; COPD=chronic obstructive
pulmonary disease; CPB=cardiopulmonary bypass; CVD=cerebral vascular
disease; CVP=central venous pressure by ICU admittance; DM=diabetes
mellitus; eGFR=estimated glomerular filtration rate, as calculated based
on the Cockcroft- Gault formulae for SRI score validation; LCOS=low
cardiac output syndrome; LVEF=left ventricular ejection fraction;
NYHA=New York Heart Association; SCr=serum creatinine; SD=standard
deviation</p></fn></table-wrap-foot></table-wrap><p>The incidence of AKI was 37.4% (594/1587), while the incidence of RRT-AKI was 1.1%
(18/1587) and the mortality of AKI and RRT-AKI were 6.1% (36/594) and 66.7% (12/18),
respectively. The total mortality was 2.8% (44/1587). The discrimination (AUC, 95%
CI) for both the prediction of CSA-AKI of AKICS (0.610, 95% CI 0.59 to 0.65) (<xref ref-type="fig" rid="f1">Figure 1</xref>) and the prediction of RRT-AKI of
Cleveland score (0.684, 95% CI 0.57 to 0.79) and SRI (0.622, 95% CI 0.49 to 0.75)
were low, while Mehta score (0.708, 95% CI 0.60 to 0.81) indicated barely fair
discrimination (<xref ref-type="fig" rid="f2">Figure 2</xref>). On the other side,
calibration of AKICS score (x<sup>2</sup>=7.55, <italic>P</italic>=0.109), Cleveland
score (x<sup>2</sup>=1.918, <italic>P</italic>=0.166), Mehta score
(x<sup>2</sup>=9.209, <italic>P</italic>=0.238) and SRI (x<sup>2</sup>=2.976,
<italic>P</italic>=0.271) were fair. Compared to the expected incidence, in our
study, AKICS score far underestimated the incidence of AKI, and the other models
overestimated the incidence of RRT-AKI slightly (<xref ref-type="table" rid="t3">Table 3</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>ROC curve for the prediction of CSA-AKI of AKICS score.</p></caption><graphic xlink:href="rbccv-32-06-0481-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>ROC curves for the prediction of RRT-AKI of Cleveland score, Mehta score
and SRI.</p></caption><graphic xlink:href="rbccv-32-06-0481-g02"/></fig>
</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison between predicted and observed outcomes for each score.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">&#x000a0;</th><th align="center" colspan="2" rowspan="1">AKI</th><th align="center" colspan="2" rowspan="1">RRT-AKI</th></tr><tr><th align="center" rowspan="1" colspan="1">AKICS (n=1585)</th><th align="center" rowspan="1" colspan="1">Cleveland (n=1587)</th><th align="center" rowspan="1" colspan="1">Mehta (n=1587)</th><th align="center" rowspan="1" colspan="1">SRI (n=1587)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Predicted</td><td align="center" rowspan="1" colspan="1">14%</td><td align="center" rowspan="1" colspan="1">1.7%</td><td align="center" rowspan="1" colspan="1">1.4%</td><td align="center" rowspan="1" colspan="1">1.3-2.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">Observed</td><td align="center" rowspan="1" colspan="1">37.4%</td><td align="center" rowspan="1" colspan="1">1.1%</td><td align="center" rowspan="1" colspan="1">1.1%</td><td align="center" rowspan="1" colspan="1">1.1%</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>AKI=acute kidney injury</p></fn><fn id="TFN4"><p>The predicted incidences of each outcome were derived from the origin
papers.</p></fn></table-wrap-foot></table-wrap><p>Although the purpose of the study was to evaluate patients according to the KDIGO
criteria, we presented a subanalysis using the AKICS criteria for CSA-AKI.</p><p>CSA-AKI criteria in AKICS study: an increase of SCr levels above than 2.0 mg/dL in
patients with baseline SCr lower than 1.5 mg/dL. In patients with baseline
creatinine between 1.5 and 3.0 mg/dL, AKI was defined as a creatinine increase of
50% over the baseline value.</p><p>The incidence of CSA-AKI resulted from the AKICS criteria is lower than that from the
KDIGO definition (22.8% <italic>vs.</italic> 37.4%,
<italic>P</italic>&#x0003c;0.001).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>As one of the most common complications of cardiac surgery, AKI plays an important
role in worsening prognosis. In the past decades, the incidence of CSA-AKI varies
between 8.9% and 39%, according to different definition<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Some
revealed reasons for the wide range of incidence are the difference between
underlying disease, procedure types, comorbidities, ethics and medical care
development in global population.</p><p>Since early prediction in those patients at high risk of developing CSA-AKI may
contribute to prevention of complications, in the last two decades various
predictive models have been developed to forecast CSA-AKI or RRT-AKI after cardiac
surgery. Among those risk scores, adequate predictive power in the method published
by Palomba et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>, the Cleveland
Clinic score<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, the scoring system
published by Mehta et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> and
the simplified renal index score<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>
were validated among Caucasians<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. However, with the developing of
AKI academic community, especially the publication of KDIGO guideline and
recognition of intraoperative and post-operative risk factors, utilizing these risk
scores in population other than Caucasians, and cohorts with more valve surgeries
and less diabetes become questionable. With the development of medical technology,
the cardiac surgery in developing countries like China is booming. Meanwhile, the
complication of surgery and economic burden are also increasing due to relatively
low medical technology and management. Compared to the existing score derivation
cohorts, the incidence of CSA-AKI is much higher in developing countries like Brazil
and China<sup>[<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Thus, it is important to identify whether or not
these existing scores are good enough to predict respective outcome in patients in
developing countries.</p><p>In 2007, Palomba et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup> carried
out a single-center study to generate a risk score to predict CSA-AKI with a cohort
of 603 patients. In that study, the result of internal validation was good with
AUROC 0.84, which meant a good predictive power of AKI after cardiac surgery. By
that time, the authors had recognized the worse prognosis and long-term CKD
evolvement could be resulted from even slightly AKI. They also focused on the
intraoperative and early postoperative risk factors contributing to CSA-AKI. This
has been proven a promising milestone for subsequent authors to build predictive
risk scores. However, the validation in our study is not as good as that. Potential
reason may include: (1) The definition of AKI in the primary study was an increase
of SCr levels above than 2.0 mg/dL in patients with baseline SCr lower than 1.5
mg/dL. In patients with baseline creatinine between 1.5 and 3.0 mg/dL, AKI was
defined as a creatinine increase of 50% over the baseline value. This urine output
lacking definition may result in the missing diagnosis of CSA-AKI compared with the
KDIGO definition. (2) The Asian population in the primary study is 3.8%, while we
know the racial discrepancy may affect the validation result<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.</p><p>As for the three risk scores predicting RRT-AKI, they were generated upon deliberate
design and large sample cohorts, Mehta score<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> and SRI score<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> were established with multicenter studies, and their predictive
power have been validated sufficient among Caucasian population<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. However, their predictive power in our study were not good
enough, and we tried to find the reason. Maybe the following can explain.</p><p>Firstly, the endpoint event of the Cleveland score, Mehta score and SRI is RRT-AKI.
Though up till now, whether early RRT is beneficial remains debatable<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, some studies have shown early
initiation of RRT can reduce short-term mortality<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. However, the variability of local practices in
when to start RRT may affect the incidence significantly. As is known to all, the
key problem of risk scores is their derivation, which is strongly dependent on
characteristics of the derivation cohort and the statistical methods<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, especially when the endpoint has
a low incidence and is multifactorial. The RRT-AKI incidence in our cohort is 1.1%,
slightly lower than that in those three scores (Cleveland 1.7%, Mehta 1.4% and SRI
1.3-2.2%). This may be one of the reasons that result in their insufficient
predictive power in our study.</p><p>Secondly, despite of strict similar inclusion or exclusion criteria being utilized,
there remained much difference among our cohort and the derivation cohorts. The
proportion of valve surgery is much higher in developing countries like China than
the previous risk scores developing centers, in which CABG is majority. Compared to
CABG, the pathophysiology and pathological impairment are diversified. Patients who
undergo valve surgery typically demonstrate low stroke volume related to
regurgitation, which increases the vulnerability of the kidney to injury during
cardiac surgery. The comorbidities in developing countries like Chinese patients are
also different from Western population. In our derivation cohort, the ratio of
hypertension and diabetes mellitus is also remarkable, lower than the previous
develop population<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p><p>Nonetheless, our validation did not make the scores useless. The predictors can be
further analyzed with other newly found risk factors<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> or biomarkers so as to establish new brand risk
scores<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Along with the
discovery of intraoperative and postoperative predictors, a dynamic predictive model
for CSA-AKI/RRT-AKI based on the KDIGO AKI definition, which might be applied to
predict the incidence of CSA-AKI from preoperative to early postoperative periods,
shall meet the need. Meanwhile some limitation of our study must be noted, our
validation is a single-center study, with relatively lower sample amount.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>We carried out this study to validate four risk scores predicting CSA-AKI or RRT-AKI.
Although all scores presented good calibration in our cohort, their discrimination
were barely satisfactory with an underestimated CSA-AKI incidence by AKICS score and
overestimated RRT-AKI incidence by Cleveland score, Mehta score and SRI score.
However, the risk factors in the scores can be further analyzed to generate reliable
new risk scores.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">WJ</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; acquisition, analysis, or interpretation of data for
the work; drafting the work or revising it critically for important
intellectual content; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">JX</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; acquisition, analysis, or interpretation of data for
the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">BS</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; acquisition, analysis, or interpretation of data for
the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">CW</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">JT</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">XD</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Zhongshan Hospital of Fudan University Shanghai
Medical College, Shanghai, China.</p></fn><fn fn-type="financial-disclosure"><p>Financial Support: Clinical key specialist construction project and Shanghai
science and technology committee scientific research projects 14DZ2260200.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortes</surname><given-names>JV</given-names></name><name><surname>Silva</surname><given-names>MG</given-names></name><name><surname>Baldez</surname><given-names>TE</given-names></name><name><surname>Costa</surname><given-names>MA</given-names></name><name><surname>Silva</surname><given-names>LN</given-names></name><name><surname>Pinheiro</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Mortality risk after cardiac surgery: application of Inscor in a
university hospital in Brazil's Northeast</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>5</issue><fpage>396</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">27982349</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>NJ</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><name><surname>Graham</surname><given-names>TR</given-names></name><name><surname>Mascaro</surname><given-names>J</given-names></name><name><surname>Rooney</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Subtle changes in renal function are associated with differences
in late survival following adult cardiac surgery</article-title><source>Eur J Cardiothorac Surg</source><year>2012</year><volume>41</volume><issue>4</issue><fpage>e38</fpage><lpage>e42</lpage><pub-id pub-id-type="pmid">22423081</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassnigg</surname><given-names>A</given-names></name><name><surname>Schmidlin</surname><given-names>D</given-names></name><name><surname>Mouhieddine</surname><given-names>M</given-names></name><name><surname>Bachmann</surname><given-names>LM</given-names></name><name><surname>Druml</surname><given-names>W</given-names></name><name><surname>Bauer</surname><given-names>P</given-names></name><etal/></person-group><article-title>Minimal changes of serum creatinine predict prognosis in patients
after cardiothoracic surgery: a prospective cohort study</article-title><source>J Am Soc Nephrol</source><year>2004</year><volume>15</volume><issue>6</issue><fpage>1597</fpage><lpage>1605</lpage><pub-id pub-id-type="pmid">15153571</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candela-Toha</surname><given-names>A</given-names></name><name><surname>Elias-Martin</surname><given-names>E</given-names></name><name><surname>Abraira</surname><given-names>V</given-names></name><name><surname>Tenorio</surname><given-names>MT</given-names></name><name><surname>Parise</surname><given-names>D</given-names></name><name><surname>Pablo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Predicting acute renal failure after cardiac surgery: external
validation of two new clinical scores</article-title><source>Clin J Am Soc Nephrol</source><year>2008</year><volume>3</volume><issue>5</issue><fpage>1260</fpage><lpage>1265</lpage><pub-id pub-id-type="pmid">18463173</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Englberger</surname><given-names>L</given-names></name><name><surname>Suri</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Sundt 3rd</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Validation of clinical scores predicting severe acute kidney
injury after cardiac surgery</article-title><source>Am J Kidney Dis</source><year>2010</year><volume>56</volume><issue>4</issue><fpage>623</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">20630639</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RH</given-names></name><name><surname>Grab</surname><given-names>JD</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Bridges</surname><given-names>CR</given-names></name><name><surname>Gammie</surname><given-names>JS</given-names></name><name><surname>Haan</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Bedside tool for predicting the risk of postoperative dialysis in
patients undergoing cardiac surgery</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>21</issue><fpage>2208</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">17088458</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palomba</surname><given-names>H</given-names></name><name><surname>Castro</surname><given-names>I</given-names></name><name><surname>Neto</surname><given-names>AL</given-names></name><name><surname>Lage</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>Acute kidney injury prediction following elective cardiac
surgery: AKICS score</article-title><source>Kidney Int</source><year>2007</year><volume>72</volume><issue>5</issue><fpage>624</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">17622275</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakar</surname><given-names>CV</given-names></name><name><surname>Arrigain</surname><given-names>S</given-names></name><name><surname>Worley</surname><given-names>S</given-names></name><name><surname>Yared</surname><given-names>JP</given-names></name><name><surname>Paganini</surname><given-names>EP</given-names></name></person-group><article-title>A clinical score to predict acute renal failure after cardiac
surgery</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><issue>1</issue><fpage>162</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">15563569</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijeysundera</surname><given-names>DN</given-names></name><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Dupuis</surname><given-names>JY</given-names></name><name><surname>Rao</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>CT</given-names></name><name><surname>Granton</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Derivation and validation of a simplified predictive index for
renal replacement therapy after cardiac surgery</article-title><source>JAMA</source><year>2007</year><volume>297</volume><issue>16</issue><fpage>1801</fpage><lpage>1809</lpage><pub-id pub-id-type="pmid">17456822</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Kidney disease: improving global outcomes (KDIGO) acute kidney
injury work group</collab></person-group><article-title>KDIGO clinical practice guideline for acute kidney
injury</article-title><source>Kidney Inter</source><year>2012</year><volume>2</volume><issue>suppl</issue><fpage>1</fpage><lpage>138</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Teng</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group><article-title>Acute kidney injury in China</article-title><source>Hemodial Int</source><year>2015</year><volume>19</volume><issue>1</issue><fpage>2</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">25052456</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Teng</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Acute kidney injury in a Chinese hospitalized
population</article-title><source>Blood Purif</source><year>2010</year><volume>30</volume><issue>2</issue><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">20714143</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Teng</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group><article-title>Management of cardiac surgery-associated acute kidney
injury</article-title><source>Contrib Nephrol</source><year>2016</year><volume>187</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">26881864</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>MN</given-names></name><name><surname>Nakazone</surname><given-names>MA</given-names></name><name><surname>Maia</surname><given-names>LN</given-names></name></person-group><article-title>Acute kidney injury based on KDIGO (Kidney Disease Improving
Global Outcomes) criteria in patients with elevated baseline serum
creatinine undergoing cardiac surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>3</issue><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">25372901</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waikar</surname><given-names>SS</given-names></name><name><surname>Curhan</surname><given-names>GC</given-names></name><name><surname>Ayanian</surname><given-names>JZ</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name></person-group><article-title>Race and mortality after acute renal failure</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><issue>10</issue><fpage>2740</fpage><lpage>2748</lpage><pub-id pub-id-type="pmid">17855647</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricci</surname><given-names>Z</given-names></name><name><surname>Ronco</surname><given-names>C</given-names></name></person-group><article-title>Timing, dose and mode of dialysis in acute kidney
injury</article-title><source>Curr Opin Crit Care</source><year>2011</year><volume>17</volume><issue>6</issue><fpage>556</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">22027405</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Schmidt</surname><given-names>C</given-names></name><name><surname>Van Aken</surname><given-names>H</given-names></name><name><surname>Wempe</surname><given-names>C</given-names></name><name><surname>Pavenstadt</surname><given-names>H</given-names></name><etal/></person-group><article-title>Effect of early vs delayed initiation of renal replacement
therapy on mortality in critically ill patients with acute kidney injury:
the ELAIN randomized clinical trial</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>2190</fpage><lpage>2199</lpage><pub-id pub-id-type="pmid">27209269</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranucci</surname><given-names>M</given-names></name><name><surname>Castelvecchio</surname><given-names>S</given-names></name><name><surname>Menicanti</surname><given-names>L</given-names></name><name><surname>Frigiola</surname><given-names>A</given-names></name><name><surname>Pelissero</surname><given-names>G</given-names></name></person-group><article-title>Risk of assessing mortality risk in elective cardiac operations:
age, creatinine, ejection fraction, and the law of parsimony</article-title><source>Circulation</source><year>2009</year><volume>119</volume><issue>24</issue><fpage>3053</fpage><lpage>3061</lpage><pub-id pub-id-type="pmid">19506110</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>KA</given-names></name><name><surname>Berto</surname><given-names>B</given-names></name><name><surname>Sousa</surname><given-names>AG</given-names></name><name><surname>Costa</surname><given-names>FA</given-names></name></person-group><article-title>Prognosis and complications of diabetic patients undergoing
isolated coronary artery bypass surgery</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>1</issue><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">27074269</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocogullari</surname><given-names>CU</given-names></name><name><surname>Kunt</surname><given-names>AT</given-names></name><name><surname>Aksoy</surname><given-names>R</given-names></name><name><surname>Duzyol</surname><given-names>C</given-names></name><name><surname>Parlar</surname><given-names>H</given-names></name><name><surname>Saskin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hemoglobin a1c levels predicts acute kidney injury after coronary
artery bypass surgery in non-diabetic patients</article-title><source>Braz J Cardiovasc Surg</source><year>2017</year><volume>32</volume><issue>2</issue><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">28492788</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnie</surname><given-names>K</given-names></name><name><surname>Verheyden</surname><given-names>V</given-names></name><name><surname>Pagano</surname><given-names>D</given-names></name><name><surname>Bhabra</surname><given-names>M</given-names></name><name><surname>Tilling</surname><given-names>K</given-names></name><name><surname>Sterne</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Predictive models for kidney disease: improving global outcomes
(KDIGO) defined acute kidney injury in UK cardiac surgery</article-title><source>Crit Care</source><year>2014</year><volume>18</volume><issue>6</issue><fpage>606</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">25673427</pub-id></element-citation></ref></ref-list></back></article>